CLX
The Clorox Company Consumer Staples - Household Products Investor Relations →
The Clorox Company (CLX) closed at $106.15 as of 2026-03-20, trading 19.4% below its 200-week moving average of $131.69. This places CLX in the extreme value zone. The stock is currently moving closer to the line, down from -16.0% last week. The 14-week RSI sits at 53, indicating neutral momentum.
Trading volume is running at 1.3x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.83 ratio) is neutral — neither side is clearly dominating.
Over the past 2721 weeks of data, CLX has crossed below its 200-week moving average 21 times. On average, these episodes lasted 31 weeks. Historically, investors who bought CLX at the start of these episodes saw an average one-year return of +7.9%.
With a market cap of $12.9 billion, CLX is a large-cap stock. The company generates a free cash flow yield of 7.8%, which is healthy. Return on equity stands at 987.2%, indicating strong profitability. The stock trades at -102.7x book value.
CLX is a Dividend Aristocrat, having increased its dividend for 25 or more consecutive years. The current yield is 467.00%.
Over the past 33.2 years, a hypothetical investment of $100 in CLX would have grown to $2332, compared to $2683 for the S&P 500. CLX has returned 9.9% annualized vs 10.4% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 2 open-market purchases totaling $962,801. Notably, these purchases occurred while CLX is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been growing at a 12.5% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: CLX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After CLX Crosses Below the Line?
Across 15 historical episodes, buying CLX when it crossed below its 200-week moving average produced an average return of +5.0% after 12 months (median +6.0%), compared to +2.4% for the S&P 500 over the same periods. 57% of those episodes were profitable after one year. After 24 months, the average return was +24.9% vs +12.6% for the index.
Each line shows $100 invested at the moment CLX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
CLX has crossed below its 200-week MA 21 times with an average 1-year return of +7.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 1974 | Jan 1976 | 103 | 66.1% | -36.7% | +23610.3% |
| Feb 1976 | May 1977 | 64 | 22.2% | -18.3% | +21217.5% |
| Oct 1978 | Sep 1979 | 47 | 16.9% | -11.7% | +24619.3% |
| Sep 1979 | Mar 1981 | 75 | 31.8% | -15.5% | +23854.8% |
| Aug 1981 | Dec 1981 | 18 | 8.4% | +30.0% | +25717.9% |
| Jan 1982 | Jan 1982 | 2 | 1.5% | +111.4% | +26304.7% |
| Feb 2000 | May 2000 | 15 | 24.0% | -4.1% | +456.9% |
| Jul 2000 | Oct 2000 | 12 | 17.7% | -4.5% | +458.3% |
| Dec 2000 | Feb 2002 | 61 | 28.4% | -1.7% | +420.1% |
| Jun 2002 | Aug 2002 | 7 | 22.5% | +6.2% | +399.7% |
| Sep 2002 | Oct 2002 | 1 | 1.6% | +16.4% | +410.3% |
| Oct 2002 | Oct 2002 | 1 | 2.0% | +16.4% | +414.3% |
| Jan 2003 | Feb 2003 | 3 | 3.6% | +31.2% | +429.8% |
| Feb 2008 | Feb 2008 | 2 | 0.6% | -2.0% | +220.6% |
| Mar 2008 | Aug 2008 | 22 | 10.0% | -14.9% | +221.9% |
| Oct 2008 | Oct 2008 | 3 | 6.0% | +8.0% | +220.3% |
| Dec 2008 | Jul 2009 | 31 | 17.3% | +12.5% | +216.1% |
| Apr 2018 | Apr 2018 | 1 | 1.0% | +37.4% | +17.4% |
| Jan 2022 | Apr 2023 | 63 | 24.9% | +13.1% | -13.8% |
| May 2023 | Aug 2024 | 65 | 26.4% | -14.5% | -26.4% |
| Apr 2025 | Ongoing | 50+ | 26.6% | Ongoing | -21.9% |
| Average | 31 | — | +7.9% | — |
Frequently Asked Questions
Is CLX below its 200-week moving average?
Yes. As of 2026-03-20, The Clorox Company (CLX) is trading 19.4% below its 200-week moving average of $131.69. The current price is $106.15.
What is CLX's 200-week moving average price?
The Clorox Company's 200-week moving average is $131.69 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when CLX drops below its 200-week moving average?
CLX has crossed below its 200-week moving average 21 times in our data. On average, buying at that moment produced a one-year return of +7.9%. These dips have historically been decent entry points. These episodes lasted 31 weeks on average.
Is CLX a good value right now?
Here's what our data says about CLX as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 53. Free cash flow yield is 7.8%. Return on equity is 987.2%. Price-to-book is -102.7x. This is not a buy or sell recommendation — always do your own research.
How does CLX compare to the S&P 500?
Over the past 33.2 years, $100 invested in CLX would have grown to $2332, compared to $2683 for the S&P 500. That's 9.9% annualized vs 10.4% for the index. CLX has underperformed the broader market over this period.
Does CLX pay a dividend?
Yes. The Clorox Company currently pays a dividend yield of 467.00%. It is also a Dividend Aristocrat, meaning it has raised its dividend for 25 or more consecutive years.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20